LIQUID PHARMACEUTICAL PREPARATIONS PERLINGUAL

Brand Owner Address Description
UNIFLASH UNITHER PHARMACEUTICALS 151 rue André Durouchez Espace Industriel Nord - CS 28028 F-80084 AMIENS France Liquid pharmaceutical preparations for perlingual administration for the treatment of cough and cold, heartburn, cardiovascular disease, bowel disorder, constipation, diarrhea, pain and inflammation, headaches and cephalalgia, allergy, asthma bronchitis and chronic obstructive pulmonary disease, neurological disorder; pharmaceutical preparations being administered in order to achieve a rapid effect after administration for the treatment of cough and cold, heartburn, cardiovascular disease, bowel disorder, constipation, diarrhea, pain and inflammation, headaches and cephalalgia, allergy, asthma bronchitis and chronic obstructive pulmonary disease, neurological disorder; migraine preparations; alkaloids for medical purposes; medicinal alcohol; medical preparations for slimming purposes; analgesics; anti­ asthma preparations; antiparasitic preparations; antiseptic preparations; med icated mouth wash; medicinal oils; tranquilizers; siccative drying agents for medical purposes; single-dose capsules sold empty for pharmaceutical preparations for medical purposes;Pharmaceutical flasks for medical use; single-dose packaging for pharmaceutical aerosols; spray bottles sold empty for pharmaceuticals for medical use; metering bottles for pharmaceuticals for medical purposes;Research and development of packaging containers for pharmaceutical preparations for medical use; research and development of single-dose packaging containers; research and development of flexible single-dose packaging containers; research and development of medical products having a rapid effect after administration; research and development of medical products for perlingual administration and having a rapid effect after being taken;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.